Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma.
Blood. 2023 Jul 20;142(3):260-273. doi: 10.1182/blood.2022019451.
Blood. 2023.
PMID: 37192303
Free PMC article.
Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups.
Gomez-Bougie P, Halliez M, Maïga S, Godon C, Kervoëlen C, Pellat-Deceunynck C, Moreau P, Amiot M.
Gomez-Bougie P, et al. Among authors: kervoelen c.
Cancer Biol Ther. 2015;16(1):60-5. doi: 10.4161/15384047.2014.986997.
Cancer Biol Ther. 2015.
PMID: 25517601
Free PMC article.
Item in Clipboard
A simple flow cytometry-based barcode for routine authentication of multiple myeloma and mantle cell lymphoma cell lines.
Maïga S, Brosseau C, Descamps G, Dousset C, Gomez-Bougie P, Chiron D, Ménoret E, Kervoelen C, Vié H, Cesbron A, Moreau-Aubry A, Amiot M, Pellat-Deceunynck C.
Maïga S, et al. Among authors: kervoelen c.
Cytometry A. 2015 Apr;87(4):285-8. doi: 10.1002/cyto.a.22643. Epub 2015 Feb 16.
Cytometry A. 2015.
PMID: 25688540
Free article.
No abstract available.
Item in Clipboard
Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma.
Kervoëlen C, Ménoret E, Gomez-Bougie P, Bataille R, Godon C, Marionneau-Lambot S, Moreau P, Pellat-Deceunynck C, Amiot M.
Kervoëlen C, et al.
Oncotarget. 2015 Sep 29;6(29):26922-34. doi: 10.18632/oncotarget.4616.
Oncotarget. 2015.
PMID: 26323097
Free PMC article.
Item in Clipboard
Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes.
Seiller C, Maiga S, Touzeau C, Bellanger C, Kervoëlen C, Descamps G, Maillet L, Moreau P, Pellat-Deceunynck C, Gomez-Bougie P, Amiot M.
Seiller C, et al. Among authors: kervoelen c.
Cell Death Dis. 2020 May 5;11(5):316. doi: 10.1038/s41419-020-2505-1.
Cell Death Dis. 2020.
PMID: 32371863
Free PMC article.
Item in Clipboard
CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma.
Decombis S, Bellanger C, Le Bris Y, Madiot C, Jardine J, Santos JC, Boulet D, Dousset C, Menard A, Kervoelen C, Douillard E, Moreau P, Minvielle S, Moreau-Aubry A, Tessoulin B, Roue G, Bidère N, Le Gouill S, Pellat-Deceunynck C, Chiron D.
Decombis S, et al. Among authors: kervoelen c.
Blood. 2023 Nov 2;142(18):1543-1555. doi: 10.1182/blood.2023020211.
Blood. 2023.
PMID: 37562004
Item in Clipboard
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.
Grandclément C, Estoppey C, Dheilly E, Panagopoulou M, Monney T, Dreyfus C, Loyau J, Labanca V, Drake A, De Angelis S, Rubod A, Frei J, Caro LN, Blein S, Martini E, Chimen M, Matthes T, Kaya Z, Edwards CM, Edwards JR, Menoret E, Kervoelen C, Pellat-Deceunynck C, Moreau P, Mbow ML, Srivastava A, Dyson MR, Zhukovsky EA, Perro M, Sammicheli S.
Grandclément C, et al. Among authors: kervoelen c.
Nat Commun. 2024 Mar 6;15(1):2054. doi: 10.1038/s41467-024-46310-y.
Nat Commun. 2024.
PMID: 38448430
Free PMC article.
Item in Clipboard
Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma.
Durand R, Bellanger C, Kervoëlen C, Tessoulin B, Dousset C, Menoret E, Asnagli H, Parker A, Beer P, Pellat-Deceunynck C, Chiron D.
Durand R, et al. Among authors: kervoelen c.
Haematologica. 2024 Feb 22. doi: 10.3324/haematol.2023.284345. Online ahead of print.
Haematologica. 2024.
PMID: 38385294
Free article.
Item in Clipboard
Cite
Cite